Cargando…
Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion
Tumor hypoxia and hypoxic adaptation of cancer cells represent major barriers to successful cancer treatment. We revealed that improved antioxidant capacity contributes to increased radioresistance of cancer cells with tolerance to chronic-cycling severe hypoxia/reoxygenation stress. We hypothesized...
Autores principales: | Hansel, Christine, Hlouschek, Julian, Xiang, Kexu, Melnikova, Margarita, Thomale, Juergen, Helleday, Thomas, Jendrossek, Verena, Matschke, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616547/ https://www.ncbi.nlm.nih.gov/pubmed/34831264 http://dx.doi.org/10.3390/cells10113040 |
Ejemplares similares
-
The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia
por: Hlouschek, Julian, et al.
Publicado: (2018) -
Oncometabolites and the response to radiotherapy
por: Xiang, Kexu, et al.
Publicado: (2020) -
Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity
por: Xiang, Kexu, et al.
Publicado: (2022) -
Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown
por: Krysztofiak, Adam, et al.
Publicado: (2021) -
MTH1 counteracts oncogenic oxidative stress
por: Burton, Dominick G.A., et al.
Publicado: (2015)